322 related articles for article (PubMed ID: 31116389)
1. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure.
Pannucci CJ; Fleming KI; Holoyda K; Moulton L; Prazak AM; Varghese TK
Ann Thorac Surg; 2018 Aug; 106(2):404-411. PubMed ID: 29626461
[TBL] [Abstract][Full Text] [Related]
3. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
[TBL] [Abstract][Full Text] [Related]
4. Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose.
Wall V; Fleming KI; Tonna JE; Nunez J; Lonardo N; Shipley RW; Nirula R; Pannucci CJ
Am J Surg; 2018 Aug; 216(2):222-229. PubMed ID: 28736059
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
6. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis?
Lu P; Harms KA; Paul E; Bortz H; Lo C; Cleland H
J Plast Reconstr Aesthet Surg; 2021 Aug; 74(8):1814-1823. PubMed ID: 33414092
[TBL] [Abstract][Full Text] [Related]
8. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
9. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
[TBL] [Abstract][Full Text] [Related]
10. Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials.
Pannucci CJ; Fleming KI; Varghese TK; Stringham J; Huang LC; Pickron TB; Prazak AM; Bertolaccini C; Momeni A
Ann Surg; 2022 Dec; 276(6):e682-e690. PubMed ID: 33086312
[TBL] [Abstract][Full Text] [Related]
11. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
Pannucci CJ; Prazak AM; Scheefer M
Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
[TBL] [Abstract][Full Text] [Related]
12. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
13. Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism Prevention.
Pannucci CJ; Fleming KI; Bertolaccini C; Moulton L; Stringham J; Barnett S; Lin J; Varghese TK
Ann Thorac Surg; 2020 Jun; 109(6):1713-1721. PubMed ID: 32045583
[TBL] [Abstract][Full Text] [Related]
14. Anti-Factor Xa Monitoring of Enoxaparin Thromboembolism Prophylaxis in Emergency General Surgery Patients.
Pokrzywa CJ; Biesboer EA; Figueroa J; Al Tannir AH; de Moya M; Morris RS; Murphy PB
J Am Coll Surg; 2023 Aug; 237(2):195-203. PubMed ID: 37039364
[TBL] [Abstract][Full Text] [Related]
15. A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin.
Aleidan FAS; Aljarba GA; Aldakhil AA; Allehyani BI; Yahia MA; Alghtani NE; Badri M; Alaklabi AA; Alsuhaibani A; Crowther MA
Int J Hematol; 2020 Jul; 112(1):1-7. PubMed ID: 32266670
[TBL] [Abstract][Full Text] [Related]
16. Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial.
Wang C; Ning YC; Song LP; Li PJ; Wang FH; Ding MX; Jiang L; Wang M; Pei QQ; Hu SM; Wang H
BMJ Open; 2023 Oct; 13(10):e069742. PubMed ID: 37880168
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
[TBL] [Abstract][Full Text] [Related]
18. Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy.
Corona LE; Singhal U; Hafez K; Herrel LA; Kaffenberger SD; Montgomery JS; Morgan TM; Weizer AZ; Qin Y; Ambani SN
Urol Oncol; 2020 Oct; 38(10):797.e1-797.e6. PubMed ID: 32624425
[TBL] [Abstract][Full Text] [Related]
19. Standard Fixed Enoxaparin Dosing for Venous Thromboembolism Prophylaxis Leads to Low Peak Anti-Factor Xa Levels in Both Head and Neck and Breast Free Flap Patients.
Ambani SW; Bengur FB; Varelas LJ; Nguyen VT; Cruz C; Acarturk TO; Manders EK; Kubik MW; Sridharan S; Gimbel ML; Solari MG
J Reconstr Microsurg; 2022 Nov; 38(9):749-756. PubMed ID: 35714620
[TBL] [Abstract][Full Text] [Related]
20. Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study.
Hakeam HA; Al Duhailib Z; Alsemari M; Alwaibah RM; Al Shannan MF; Shalhoub M
Clin Appl Thromb Hemost; 2020; 26():1076029620931194. PubMed ID: 32559127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
